Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 68
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00569699 | Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) | ||
| NCT02564367 | Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction | ||
| NCT02943733 | Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs | ||
| NCT05621447 | A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects | ||
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | ||
| NCT00229424 | Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - | ||
| NCT04923529 | TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma | ||
| NCT04104139 | TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer | ||
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | ||
| NCT02562807 | A Study of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT02261532 | A Phase I Study of TAS-102 in Solid Tumors | ||
| NCT01955837 | Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia | ||
| NCT04825431 | Mass Balance Study of [14C] TAS-205 in Healthy Volunteers | ||
| NCT04074343 | TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma | ||
| NCT05773092 | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC | ||
| NCT03605251 | Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. | ||
| NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | ||
| NCT00498225 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer | ||
| NCT00569790 | Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer | ||
| NCT01904253 | A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy | ||
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | ||
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | ||
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | ||
| NCT00359567 | Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy | ||
| NCT04683250 | Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities | ||
| NCT05568095 | A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body | ||
| NCT00077142 | TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) | ||
| NCT01465464 | Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma | ||
| NCT05691660 | A Study of TAS3731 in Healthy Adults | ||
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | ||
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | ||
| NCT00569335 | Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer | ||
| NCT04608110 | A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome | ||
| NCT04999761 | AB122 Platform Study | ||
| NCT04587908 | A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） | ||
| NCT00429858 | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer | ||
| NCT01610479 | A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors | ||
| NCT04512053 | A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT02024841 | Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis | ||
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | ||
| NCT03175029 | Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. | ||
| NCT05245968 | A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) | ||
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | ||
| NCT00602745 | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen | ||
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | ||
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | ||
| NCT06608927 | Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT00737360 | Phase II Study of TAS-106 to Treat Head and Neck Cancer | ||
| NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | ||
| NCT02752048 | A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy |
